Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Gray

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)C M Gray, J Lawrence, J M Schapiro, et al.
AIDS Research and Human Retroviruses|October 6, 2000
Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cellsC M Gray, J Lawrence, E A Ranheim, et al.
Virology|November 17, 2009
Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressureF K Treurnicht, C Seoighe, D P Martin, et al.
Journal of Virology|August 31, 2012
Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progressionR S Ntale, D R Chopera, N K Ngandu, et al.
BMC Infectious Diseases|January 27, 2016
Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African womenV Naranbhai, D de Assis Rosa, L Werner, et al.
Trials|July 29, 2017
The intervention process in the European Fans in Training (EuroFIT) trial: a mixed method protocol for evaluationI van de Glind, C Bunn, C M Gray, et al.
BMJ Open|April 22, 2022
Building knowledge, optimising physical and mental health and setting up healthier life trajectories in South African women (<i>Bukhali</i>): a preconception randomised control trial part of the Healthy Life Trajectories Initiative (HeLTI)Shane A Norris, Catherine E Draper, Alessandra Prioreschi, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)C M Gray, J Lawrence, J M Schapiro, et al.
AIDS Research and Human Retroviruses|October 6, 2000
Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cellsC M Gray, J Lawrence, E A Ranheim, et al.
Virology|November 17, 2009
Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressureF K Treurnicht, C Seoighe, D P Martin, et al.
Journal of Virology|August 31, 2012
Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progressionR S Ntale, D R Chopera, N K Ngandu, et al.
BMC Infectious Diseases|January 27, 2016
Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African womenV Naranbhai, D de Assis Rosa, L Werner, et al.
Trials|July 29, 2017
The intervention process in the European Fans in Training (EuroFIT) trial: a mixed method protocol for evaluationI van de Glind, C Bunn, C M Gray, et al.
BMJ Open|April 22, 2022
Building knowledge, optimising physical and mental health and setting up healthier life trajectories in South African women (<i>Bukhali</i>): a preconception randomised control trial part of the Healthy Life Trajectories Initiative (HeLTI)Shane A Norris, Catherine E Draper, Alessandra Prioreschi, et al.
Pageof 6